Paul B. Fisher, MPh, PhD, FNAI

Dr. Paul Fisher is a professor in the Department of Cellular, Molecular, and Genetic Medicine and holds the Thelma Newmeyer Corman Chair in Cancer Research at the VCU School of Medicine in Richmond, VA. He also founded the VCU Institute of Molecular Medicine (VIMM) and has served as its director since 2008. He is an Emeritus Professor in the Departments of Pathology, Neurosurgery, and Urology at Columbia University, College of Physicians & Surgeons, New York, NY. Dr. Fisher has published over 650 papers and reviews, is among the top NIH/NCI-funded investigators, and has 55 issued patents. He pioneered novel gene-discovery approaches (including subtraction hybridization, RSDD, DISH), developed innovative therapeutic approaches (cancer therapeutic viruses, therapeutic cytokines [MDA-7/IL-24]), delivered numerous named and distinguished lectures, and founded several startup companies. He was named Virginia Outstanding Scientist of 2014, a Fellow of the National Foundation for Cancer Research, and was elected to the National Academy of Inventors in 2018. Dr. Fisher is a successful, seasoned entrepreneur. He founded GenQuest Incorporated, a functional genomics company that merged with Corixa Corporation in 1998, traded on NASDAQ, and was acquired by GlaxoSmithKline in 2006. He co-founded InVaMet Therapeutics (IVMT), which develops small-molecule inhibitors of metastasis, and InterLeukin Combinatorial Therapies (ILCT), which advances therapeutic interleukins/cytokines from bench to bedside.